Shiga Toxin 2a–Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis

• Published in: The Journal of infectious diseases Vol. 213; no. 6; pp. 1031 - 1040
• Main Authors: Betzen, Christian, Plotnicki, Kathrin, Fathalizadeh, Farnoosh, Pappan, Kirk, Fleming, Thomas, Bielaszewska, Martina, Karch, Helge, Tönshoff, Burkhard, Rafat, Neysan
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 15.03.2016
• Subjects: Cells, Cultured; Eicosanoids - genetics; Eicosanoids - metabolism; Endothelial Cells - drug effects; Escherichia coli; Escherichia coli - genetics; Escherichia coli - metabolism; Gene Expression Regulation - drug effects; Hemolytic-Uremic Syndrome - metabolism; Hemolytic-Uremic Syndrome - microbiology; Hemolytic-Uremic Syndrome - pathology; Humans; Kidney Glomerulus - cytology; Metabolomics; PATHOGENESIS AND HOST RESPONSE; Shiga Toxin 2 - toxicity; endothelial cells; Shiga toxin; metabolomics; hemolytic uremic syndrome
• ISSN: 0022-1899; 1537-6613; 1537-6613
• DOI: 10.1093/infdis/jiv540

Background. Endothelial dysfunction plays a pivotal role in the pathogenesis of postenteropathic hemolytic uremic syndrome (HUS), most commonly caused by Shiga toxin (Stx)–producing strains of Escherichia coli. Methods. To identify new treatment targets, we performed a metabolomic high-throughput screening to analyze the effect of Stx2a, the major Stx type associated with HUS, on human renal glomerular endothelial cells (HRGEC) and umbilical vein endothelial cells (HUVEC). Cells were treated either with sensitizing tumor necrosis factor α (TNF-α) or Stx2a, a sequence of both or remained untreated. Results. We identified 341 metabolites by combined liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Both cell lines exhibited distinct metabolic reaction profiles but shared elevated levels of free fatty acids. Stx2a predominantly altered the nicotinamide adenine dinucleotide (NAD) cofactor pathway and the inflammation-modulating eicosanoid pathway, which are associated with lipid metabolism. In HRGEC, Stx2a strongly diminished NAD derivatives, leading to depletion of the energy substrate acetyl coenzyme A and the antioxidant glutathione. HUVEC responded to TNF-α and Stx2a by increasing production of the counteracting eicosanoids prostaglandin I2, E1, E2, and A2, while in HRGEC only more prostaglandin I2 was detected. Conclusions. We conclude that disruption of energy metabolism and depletion of glutathione contributes to Stx-induced injury of the renal endothelium and that the inflammatory response to Stx is highly cell-type specific.